Search

Your search keyword '"Wragg, Christopher"' showing total 47 results

Search Constraints

Start Over You searched for: Author "Wragg, Christopher" Remove constraint Author: "Wragg, Christopher"
47 results on '"Wragg, Christopher"'

Search Results

1. Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial

2. Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta‐analysis based on a Cochrane systematic review

3. Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma

4. Prevalence and architecture of de novo mutations in developmental disorders

5. Measures of Phonological Short-Term Memory and Their Relationship to Vocabulary Development.

6. Germline predisposition to haematological malignancies: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene‐CanVar and the NHS England Haematological Oncology Working Group.

10. Author Correction: CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language

11. MGMTpromoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Systematic Review

12. Prognostic value of test(s) for O6-methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide

13. Heterozygous Variants in KMT2E Cause a Spectrum of Neurodevelopmental Disorders and Epilepsy

14. Bi-allelic Loss-of-Function CACNA1B Mutations in Progressive Epilepsy-Dyskinesia

16. Histone Lysine Methylases and Demethylases in the Landscape of Human Developmental Disorders

17. CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language

18. Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial

19. Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma

20. Heterozygous Variants in KMT2E Cause a Spectrum of Neurodevelopmental Disorders and Epilepsy

21. Bi-allelic Loss-of-Function CACNA1B Mutations in Progressive Epilepsy-Dyskinesia

22. Prognostic value of test(s) for O6 -methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide

25. Mutations in the histone methyltransferase gene KMT2B cause complex early-onset dystonia

27. Histone Lysine Methylases and Demethylases in the Landscape of Human Developmental Disorders

28. Prevalence, phenotype and architecture of developmental disorders caused by de novo mutation: The Deciphering Developmental Disorders Study

29. Evaluation of enzymatic techniques for screening amphetamines and alcohol in oral fluid

30. EBF1-PDGFRΒ Fusion in Paediatric Acute Lymphoblastic Leukaemia (ALL): Genetic Profile and Clinical Implications

31. EGFR and EGFRvIII analysis in glioblastoma as therapeutic biomarkers

33. Mutations in the histone methyltransferase gene KMT2B cause complex early-onset dystonia

34. EBF1-PDGFRBfusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications

35. EGFR and EGFRvlll analysis in glioblastoma as therapeutic biomarkers.

36. Next generation sequencing of chromosomal rearrangements in patients with split-hand/split-foot malformation provides evidence for DYNC1I1 exonic enhancers of DLX5/6 expression in humans.

37. Mutations in the histone methyltransferase gene KMT2B cause complex early-onset dystonia

38. Mutations in the histone methyltransferase gene KMT2B cause complex early-onset dystonia (vol 49, pg 223, 2017)

39. Evaluation of enzymatic techniques for screening amphetamines and alcohol in oral fluid

40. Evaluation of enzymatic techniques for screening amphetamines and alcohol in oral fluid

41. Evaluation of enzymatic techniques for screening amphetamines and alcohol in oral fluid

42. Evaluation of enzymatic techniques for screening amphetamines and alcohol in oral fluid

43. Evaluation of enzymatic techniques for screening amphetamines and alcohol in oral fluid

44. Evaluation of enzymatic techniques for screening amphetamines and alcohol in oral fluid

46. Corrigendum: Mutations in the histone methyltransferase gene KMT2B cause complex early-onset dystonia

47. EBF1-PDGFRΒFusion in Paediatric Acute Lymphoblastic Leukaemia (ALL): Genetic Profile and Clinical Implications

Catalog

Books, media, physical & digital resources